REVEALED: 24 - The Real Truth

AstraZeneca's Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular Disease

AstraZeneca Plc (NASDAQ:AZN) shared new and prolonged follow-up results from the Phase 3 CHAMPION-MG trial open-label extension (OLE) of Ultomiris (ravulizumab-cwvz) in generalized myasthenia gravis (gMG). Ultomiris demonstrated long-term efficacy, with improvements in activities of daily living, muscle strength, and quality of life sustained through 60 weeks. Ultomiris was also well tolerated throughout…

Benzinga · Apr 6, 2022

Why Big Pharma loves Tim Scott

During the second half of 2021, Scott was the top recipient of drug campaign cash in Congress

Salon · Apr 3, 2022

Big Pharma is betting on bigger political ambitions from Sen. Tim Scott

Sen. Tim Scott, a rising star in the Republican Party with broad popularity in his home state of South Carolina, is getting showered with drug industry money before facing voters this fall.

Tribune News Service · Mar 29, 2022

Evusheld is becoming hard to find

As immunocompromised people work to get a potentially life saving covid therapy, it's becoming harder to locate

Salon · Mar 26, 2022

AstraZeneca steps up to tackle climate change

As the world's leading biopharmaceutical company, AstraZeneca understands how crucial it is to push the boundaries of science and deliver life-changing medicines in record time. The strong dedication to creating a better and healthier future for all, including those living in Thailand, is attested by supplying over 2.8 billion doses…

Bangkok Post · Mar 25, 2022

Do I Need A Booster If I’ve Had The Spicy Cough & All Your Other Third Dose Questions Answered

If you're yet to get your third dose of a COVID-19 vaccine, we answer all of your vaccine questions in the below.

Pedestrian.tv · Mar 25, 2022

EU regulator advises AstraZeneca's COVID drug be cleared

The European Union's drug regulator says it's recommending that an antibody drug developed by AstraZeneca be authorized to help people avoid getting sick with the coronavirus

The Independent UK · Mar 24, 2022

EMA Recommends Approval Of AstraZeneca's COVID-19 Therapy, Evusheld

EMA's human medicines committee (CHMP) has 

Benzinga · Mar 24, 2022

AstraZeneca's Imfinzi Flunks In Late-Stage Advanced Cervical Cancer Study

AstraZeneca Plc's (NASDAQ:AZN) Imfinzi (durvalumab) and chemoradiotherapy did not achieve the primary goal of improving survival in patients with locally advanced cervical cancer. The Phase 3 study, dubbed "CALLA," tested progression-free survival of patients with the combination against chemoradiotherapy alone. "While the results were not what we hoped for, insights from the trial…

Benzinga · Mar 24, 2022

Tragedy as girl, 18, dies of blood clot two weeks after Covid vaccine

Kasey Turner experienced 'thunder clap' headaches from thrombosis in her sinus cavity

Manchester Evening News · Mar 24, 2022